In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoter

Infection and Immunity

Volumn 79, Issue 6, 2011, Pages 2481-2488

  Janis, Carole ^a,c   Grant, Andrew J ^a   McKinley, Trevelyan J ^a   Morgan, Fiona J E ^a   John, Victoria F ^a,b   Houghton, Jenny ^a   Kingsley, Robert A ^b   Dougan, Gordon ^b   Mastroeni, Pietro ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c Argene SA Parc Technologique Delta Sud   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIGEN VI; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPI 7 BACTERIAL GENE; SPLEEN; SSAG BACTERIAL GENE;

ANIMALS; ANTIBODIES, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LIVER; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; POLYSACCHARIDES, BACTERIAL; PROMOTER REGIONS, GENETIC; SALMONELLA TYPHI; SPLEEN; TYPHOID FEVER;

EID: 79959398494     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01265-10     Document Type: Article

References (40)

1. Acharya, I. L., et al. 1987. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella Typhi. A preliminary report. N. Engl. J. Med. 317:1101-1104.
2. Arricau, N., et al. 1998. The RcsB-RcsC regulatory system of Salmonella Typhi differentially modulates the expression of invasion proteins, flagellin and Vi antigen in response to osmolarity. Mol. Microbiol. 29:835-850.
3. Baker, S., M. Favorov, and G. Dougan. 2010. Searching for the elusive typhoid diagnostic. BMC Infect. Dis. 10:45.
4. Cherepanov, P. P., and W. Wackernagel. 1995. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158:9-14.
5. Crump, J. A., and E. Z. Mintz. 2010. Global trends in typhoid and paratyphoid fever. Clin. Infect. Dis. 50:241-246.
6. Cryz, S. J., Jr., et al. 1989. Construction and characterization of a Vi-positive variant of the Salmonella Typhi live oral vaccine strain Ty21a. Infect. Immun. 57:3863-3868.
7. Daniels, D. L., R. Schneerson, W. M. Egan, S. C. Szu, and J. B. Robbins. 1989. Characterization of the Salmonella Paratyphi C Vi polysaccharide. Infect. Immun. 57:3159-3164.
8. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
9. Dower, W. J., J. F. Miller, and C. W. Ragsdale. 1988. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 16:6127-6145.
10. Faucher, S. P., S. Porwollick, C. M. Dozois, M. McClelland, and F. Daigle. 2006. Transcriptome of Salmonella enterica serovar Typhi within macrophages revealed through the selective capture of transcribed sequences. Proc. Natl. Acad. Sci. U. S. A. 103:1906-1911.
11. Guzman, C. A., et al. 2006. Vaccines against typhoid fever. Vaccine 24:3804- 3811.
12. Hale, C., et al. 2006. Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis. Vaccine 24:4312-4320.
13. Haragga, A., M. B. Ohlson, and S. I. Miller. 2008. Salmonellae interplay with host cells. Nat. Rev. Microbiol. 6:53-66.
14. Harrison, J. A., B. Villarreal-Ramos, P. Mastroeni, R. Cemarco de Hormaeche, and C. E. Hormaeche. 1997. Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model. Immunology 90:618-625.
15. Hautefort, I., M. J. Proença, and J. C. D. Hinton. 2003. Single-copy green fluorescent protein gene fusions allow accurate measurement of Salmonella gene expression in vitro and during infection of mammalian cells. Appl. Environ. Microbiol. 69:7480-7491.
16. Hirose, K., et al. 1997. Survival of Vi-capsulated and Vi-deleted Salmonella typhi strains in cultured macrophage expressing different levels of CD14 antigen. FEMS Microbiol. Lett. 147:259-265.
17. Hothorn, T., F. Bretz, and P. Westfall. 2008. Simultaneous inference in general parametric models. Biom. J. 50:346-363.
18. Khan, C. M., et al. 1994. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc. Natl. Acad. Sci. U. S. A. 91:11261-11265.
19. Kopecko, D. J., et al. 2009. Genetic stability of vaccine strain Salmonella Typhi Ty21a over 25 years. Int. J. Med. Microbiol. 299:233-246.
20. Kossaczka, Z., et al. 1999. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect. Immun. 67:5806-5810.
21. Kox, L. F., M. M. Wosten, and E. A. Groisman. 2000. A small protein that mediates the activation of a two-component system by another two-component system. EMBO J. 19:1861-1872.
22. Lin, F. Y., et al. 2001. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N. Engl. J. Med. 344:1263-1269.
23. McKelvie, N. D., et al. 2004. Expression of heterologous antigens in Salmonella Typhimurium vaccine vectors using the in vivo-inducible, SPI-2 promoter, ssaG. Vaccine 22:3243-3255.
24. Mo, E., S. E. Peters, C. Willers, D. J. Maskell, and I. G. Charles. 2006. Single, double and triple mutants of Salmonella enterica serovar Typhimurium degP (htrA), degQ (hhoA) and degS (hhoB) have diverse phenotypes on exposure to elevated temperature and their growth in vivo is attenuated to different extents. Microb. Pathog. 41:174-182.
25. Pickard, D., et al. 1994. Characterization of defined ompR mutants of Salmonella Typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infect. Immun. 62:3984-3993.
26. Rafatellu, M., et al. 2005. The Vi capsule antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect. Immun. 73:3367-3374.
27. R Development Core Team. 2008. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org.
28. Robbins, J. D., and J. B. Robbins. 1984. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J. Infect. Dis. 150:436-449.
29. Sambrook, J., and D. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Tacket, C. O., et al. 1991. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies. J. Infect. Dis. 163:901-904.
31. Tacket, C. O., M. F. Pasetti, M. B. Sztein, S. Livio, and M. M. Levine. 2004. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. J. Infect. Dis. 190:565-570.
32. Tacket, C. O., and M. M. Levine. 2007. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression. Clin. Infect. Dis. 45: S20-S23.
33. Tran, Q. T., et al. 2010. The Salmonella enterica serotype Typhi Vi capsular antigen is expressed after the bacterium enters the ileal mucosa. Infect. Immun. 78:527-535.
34. Uppington, H., et al. 2006. Effect of immune serum and role of individual Fcgamma receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophages. Immunology 119:147-158.
35. Virlogeux, I., H. Waxin, C. Ecobichon, and M. Popoff. 1995. Role of the viaB locus in synthesis, transport and expression of Salmonella Typhi Vi antigen. Microbiology 141:3039-3047.
36. Waxin, H., I. Virlogeux, S. Kolyva, and M. Y. Popoff. 1993. Identification of six open reading frames in the Salmonella enterica subsp. enterica ser. Typhi viaB locus involved in Vi antigen production. Res. Microbiol. 144:363-371.
37. Wilson, R. P., et al. 2008. The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell. Microbiol. 10:876-890.
38. Winter, S. E., et al. 2009. The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity. Mol. Microbiol. 74:175-193.
39. Winter, S. E., et al. 2010. A rapid change in virulence gene expression during the transition from the intestinal lumen into tissue promotes systemic dissemination of Salmonella. PLoS Pathog. 6:e1001060.
40. Zhao, L., et al. 2001. Vi-suppressed wild strain Salmonella Typhi cultured in high osmolarity is hyperinvasive toward epithelial cells and destructive of Peyer's patches. Microbiol. Immunol. 45:149-158.